Treatment of toxicity from amphetamines, related derivatives, and analogues: A systematic clinical review

Drug and Alcohol Dependence

Volumn 150, Issue , 2015, Pages 1-13

  Richards, John R ^a   Albertson, Timothy E ^a,b   Derlet, Robert W ^a   Lange, Richard A ^c   Olson, Kent R ^d,f   Horowitz, B Zane ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Section of Hematology and Oncology   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Agitation; Amphetamines; Beta blockers; Hypertension; Sedation; Tachycardia

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMPHETAMINE; AMPHETAMINE DERIVATIVE; ARIPIPRAZOLE; ATENOLOL; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DEXMEDETOMIDINE; DROPERIDOL; HALOPERIDOL; KETAMINE; LORAZEPAM; METHAMPHETAMINE; NEUROLEPTIC AGENT; NIFEDIPINE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; OLANZAPINE; PHENTOLAMINE; PLACEBO; PRACTOLOL; PROPOFOL; PROPRANOLOL; QUETIAPINE; RISPERIDONE; UNINDEXED DRUG; VASODILATOR AGENT; ZIPRASIDONE; ADRENERGIC RECEPTOR BLOCKING AGENT; HYPNOTIC SEDATIVE AGENT;

ABSENCE OF SIDE EFFECTS; AGITATION; AKATHISIA; BEHAVIOR DISORDER; CLINICAL TRIAL (TOPIC); CONTINUOUS INFUSION; DRUG EFFICACY; DRUG INDICATION; DRUG OVERDOSE; DRUG SAFETY; DYSTONIA; EVIDENCE BASED MEDICINE; EXTRAPYRAMIDAL SYMPTOM; HUMAN; HYPERADRENERGIC STATE; HYPERTENSION; LIMB ISCHEMIA; METABOLIC DISORDER; MULTIPLE DRUG DOSE; NEUROLEPTIC MALIGNANT SYNDROME; NONHUMAN; OUTCOME ASSESSMENT; POSITIVE SYNDROME; PRIORITY JOURNAL; PSYCHOSIS; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK BENEFIT ANALYSIS; SINGLE DRUG DOSE; SYSTEMATIC REVIEW; TACHYCARDIA; UNSPECIFIED SIDE EFFECT; AKATHISIA, DRUG-INDUCED; CHEMICALLY INDUCED; PROSPECTIVE STUDY; PSYCHOSES, SUBSTANCE-INDUCED;

ADRENERGIC ANTAGONISTS; AKATHISIA, DRUG-INDUCED; AMPHETAMINES; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; DEXMEDETOMIDINE; HUMANS; HYPERTENSION; HYPNOTICS AND SEDATIVES; PROSPECTIVE STUDIES; PSYCHOSES, SUBSTANCE-INDUCED; TACHYCARDIA;

EID: 84926416101     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2015.01.040     Document Type: Review

References (143)

1. Akay S., Ozdemir M. Acute coronary syndrome presenting after pseudoephedrine use and regression with beta-blocker therapy. Can. J. Cardiol. 2008, 24:86-88.
2. Akingbola O.A., Singh D. Dexmedetomidine to treat lisdexamfetamine overdose and serotonin toxidrome in a 6-year-old girl. Am. J. Crit. Care 2012, 21:456-459.
3. Alevizos B. Dependence and chronic psychosis with d-nor-pseudoephedrine. Eur. Psychiatry 2003, 18:423-425.
4. Ali W.M., Al Habib K.F., Al-Motarreb A., Singh R., Hersi A., Al Faleh H., Asaad N., Al Saif S., Almahmeed W., Sulaiman K., Amin H., Al-Lawati J., Al Bustani N., Al-Sagheer N.Q., Al-Qahtani A., Al Suwaidi J. Acute coronary syndrome and khat herbal amphetamine use: an observational report. Circulation 2011, 124:2681-2689.
5. Alletag M.J., Auerbach M.A., Baum C.R. Ketamine, propofol, and ketofol use for pediatric sedation. Pediatr. Emerg. Care 2012, 28:1391-1395.
6. Anderson J.L., Adams C.D., Antman E.M., Bridges C.R., Califf R.M., Casey D.E., Chavey W.E., Fesmire F.M., Hochman J.S., Levin T.N., Lincoff A.M., Peterson E.D., Theroux P., Wenger N.K., Wright R.S., Jneid H., Ettinger S.M., Ganiats T.G., Philippides G.J., Jacobs A.K., Halperin J.L., Albert N.M., Creager M.A., DeMets D., Guyton R.A., Kushner F.G., Ohman E.M., Stevenson W., Yancy C.W. 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 2013, 61:179-347.
7. Andolfatto G., Abu-Laban R.B., Zed P.J., Staniforth S.M., Stackhouse S., Moadebi S., Willman E. Ketamine-propofol combination (ketofol) versus propofol alone for emergency department procedural sedation and analgesia: a randomized double-blind trial. Ann. Emerg. Med. 2012, 59:504-512.
8. Angrist B., Lee H.K., Gershon S. The antagonism of amphetamine-induced symptomatology by a neuroleptic. Am. J. Psychiatry 1974, 131:817-819.
9. Angrist B., Sanfilipo M., Wolkin A. Cardiovascular effects of 0.5milligrams per kilogram oral d-amphetamine and possible attenuation by haloperidol. Clin. Neuropharmacol. 2001, 24:139-144.
10. Bagdure D.N., Bhoite G.R., Reiter P.D., Dobyns E.L. Dexmedetomidine in a child with methylphenidate intoxication. Indian J. Pediatr. 2013, 80:343-344.
11. Bajaj N., Mullen D., Wylie S. Dependence and psychosis with 4-methylmethcathinone (mephedrone) use. BMJ Case Rep. 2010, 10.1136/bcr.02.2010.2780.
12. Bal T.S., Gutteridge D.R., Johnson B., Forrest A.R. Adverse effects of the use of unusual phenethylamine compounds sold as illicit amphetamine. Med. Sci. Law 1989, 29:186-188.
13. Bassi S., Rittoo D. Ecstasy and chest pain due to coronary artery spasm. Int. J. Cardiol. 2005, 99:485-487.
14. Baumann B.M., Perrone J., Hornig S.E., Shofer F.S., Hollander J.E. Randomized, double-blind, placebo-controlled trial of diazepam, nitroglycerin, or both for treatment of patients with potential cocaine-associated acute coronary syndromes. Acad. Emerg. Med. 2000, 7:878-885.
15. Beach S.R., Celano C.M., Noseworthy P.A., Januzzi J.L., Huffman J.C. QTc prolongation, torsades de pointes, and psychotropic medications. Psychosomatics 2013, 54:1-13.
16. Bingham C., Beaman M., Nicholls A.J., Anthony P.P. Necrotizing renal vasculopathy resulting in chronic renal failure after ingestion of methamphetamine and 3,4-methylenedioxymethamphetamine ('ecstasy'). Nephrol. Dial. Transplant. 1998, 13:2654-2655.
17. Bowen J.S., Davis G.B., Kearney T.E., Bardin J. Diffuse vascular spasm associated with 4-bromo-2,5-dimethoxyamphetamine ingestion. JAMA 1983, 249:1477-1479.
18. Brogan W.C., Lange R.A., Kim A.S., Moliterno D.J., Hillis L.D. Alleviation of cocaine-induced coronary vasoconstriction by nitroglycerin. J. Am. Coll. Cardiol. 1991, 18:581-586.
19. Burkhart K.K. Intravenous propranolol reverses hypertension after sympathomimetic overdose: two case reports. J. Toxicol. Clin. Toxicol. 1992, 30:109-114.
20. Burnett A.M., Salzman J.G., Griffith K.R., Kroeger B., Frascone R.J. The emergency department experience with prehospital ketamine: a case series of 13 patients. Prehosp. Emerg. Care 2012, 16:553-559.
21. Caldicott D.G.E., Edwards N.A., Kruys A., Kirkbride K.P., Sims D.N., Byard R.W., Prior M., Irvine R.J. Dancing with "death": p-methoxyamphetamine overdose and its acute management. J. Toxicol. Clin. Toxicol. 2003, 41:143-154.
22. Chan W.L., Wood D.M., Hudson S., Dargan P.I. Acute psychosis associated with recreational use of benzofuran 6-(2-aminopropyl)benzofuran (6-APB) and cannabis. J. Med. Toxicol. 2013, 9:278-281.
23. Chung A.K., Chua S.E. Effects on prolongation of Bazett's corrected QT interval of seven second-generation antipsychotics in the treatment of schizophrenia: a meta-analysis. J. Psychopharmacol. 2011, 25:646-666.
24. Cloutier R.L., Hendrickson R.G., Fu R.R., Blake B. Methamphetamine-related psychiatric visits to an urban academic emergency department: an observational study. J. Emerg. Med. 2013, 45:136-142.
25. Davis G.G., Swalwell C.I. Acute aortic dissections and ruptured berry aneurysms associated with methamphetamine abuse. J. Forensic Sci. 1994, 39:1481-1485.
26. de la Torre R., Yubero-Lahoz S., Pardo-Lozano R., Farre M. MDMA, methamphetamine, and CYP2D6 pharmacogenetics: what is clinically relevant?. Front. Genet. 2012, 3:235.
27. Derreza H., Fine M.D., Sadaniantz A. Acute myocardial infarction after use of pseudoephedrine for sinus congestion. J. Am. Board Fam. Pract. 1997, 10:436-438.
28. Dore G., Sweeting M. Drug-induced psychosis associated with crystalline methamphetamine. Australas. Psychiatry 2006, 14:86-89.
29. Duvernoy W.F. Positive phentolamine test in hypertension induced by a nasal decongestant. N. Engl. J. Med. 1969, 280:877.
30. Espelin D.E., Done A.K. Amphetamine poisoning. Effectiveness of chlorpromazine. N. Engl. J. Med. 1968, 278:1361-1365.
31. Fabian J.E., Silverstone P.H. Diltiazem, a calcium antagonist, partly attenuates the effects of dextroamphetamine in healthy volunteers. Int. Clin. Psychopharmacol. 1997, 12:113-120.
32. Farnia V., Shakeri J., Tatari F., Juibari T.A., Yazdchi K., Bajoghli H., Brand S., Abdoli N., Aghaei A. Randomized controlled trial of aripiprazole versus risperidone for the treatment of amphetamine-induced psychosis. Am. J. Drug Alcohol Abuse 2014, 40:10-15.
33. Flavahan N.A. Phenylpropanolamine constricts mouse and human blood vessels by preferentially activating alpha2-adrenoceptors. J. Pharmacol. Exp. Ther. 2005, 313:432-439.
34. Fleckenstein A.E., Volz T.J., Riddle E.L., Gibb J.W., Hanson G.R. New insights into the mechanism of action of amphetamines. Annu. Rev. Pharmacol. Toxicol. 2007, 47:681-698.
35. Ford J.B., Albertson T.E., Owen K.P., Sutter M.E., McKinney W.B. Acute, sustained chorea in children after supratherapeutic dosing of amphetamine-derived medications. Pediatr. Neurol. 2012, 47:216-218.
36. Forster A., Gardaz J.P., Suter P.M., Gemperle M. Respiratory depression by midazolam and diazepam. Anesthesiology 1980, 53:494-497.
37. Freeman K., Feldman J.A. Cocaine, myocardial infarction, and beta-blockers: time to rethink the equation?. Ann. Emerg. Med. 2008, 51:130-134.
38. Garnier L.M., Arria A.M., Caldeira K.M., Vincent K.B., O'Grady K.E., Wish E.D. Sharing and selling of prescription medications in a college student sample. J. Clin. Psychiatry 2010, 71:262-269.
39. Gary N.E., Saidi P. Methamphetamine intoxication. A speedy new treatment. Am. J. Med. 1978, 64:537-540.
40. Gedevanishvili A., Chamoun A., Uretsky B.F., Rahman A.M. Acute coronary syndrome induced by intravenous ephedrine in pregnant woman with normal coronaries. Can. J. Clin. Pharmacol. 2004, 11:195-198.
41. Gehlawat P., Singh P., Gupta R., Arya S. Mephentermine dependence with psychosis. Gen. Hosp. Psychiatry 2013, 35:9-10.
42. Goldberg M.E., Seltzer J.L., Azad S.S., Smullens S.N., Marr A.T., Larijani G.E. Intravenous labetalol for the treatment of hypertension after carotid endarterectomy. J. Cardiothorac. Anesth. 1989, 3:411-417.
43. Grześk G., Polak G., Grabczewska Z., Kubica G., Polak G., Grabczewska Z., Kubica J. Myocardial infarction with normal coronary arteriogram: the role of ephedrine-like alkaloids. Med. Sci. Monit. 2004, 10:15-21.
44. Gunn V.L., Taha S.H., Liebelt E.L., Serwint J.R. Toxicity of over-the-counter cough and cold medications. Pediatrics 2001, 108.
45. Haddad P.M., Dursun S.M. Neurological complications of psychiatric drugs: clinical features and management. Hum. Psychopharmacol. 2008, 23(Suppl. 1):15-26.
46. Hamer R., Phelps D. Inadvertent intra-arterial injection of phentaramine: a complication of drug abuse. Ann. Emerg. Med. 1981, 10:148-150.
47. Hassan N.A., Gunaid A.A., El-Khally F.M., Al-Noami M.Y., Murray-Lyon I.M. Khat chewing and arterial blood pressure. A randomized controlled clinical trial of alpha-1 and selective beta-1 adrenoceptor blockade. Saudi Med. J. 2005, 26:537-541.
48. Hawley L.A., Auten J.D., Matteucci M.J., Decker L., Hurst N., Beer W., Clark R.F. Cardiac complications of adult methamphetamine exposures. J. Emerg. Med. 2013, 45:821-827.
49. Henderson T. Neuroleptic malignant syndrome in adolescents: four probable cases in the Western Cape. S. Afr. Med. J. 2011, 101:405-407.
50. Hendrickson R.G., Cloutier R., McConnell K.J. Methamphetamine-related emergency department utilization and cost. Acad. Emerg. Med. 2008, 15:23-31.
51. Heyman S.N., Mevorach D., Ghanem J. Hypertensive crisis from chronic intoxication with nasal decongestant and cough medications. DICP 1991, 25:1068-1070.
52. Honderick T., Williams D., Seaberg D., Wears R. A prospective, randomized, controlled trial of benzodiazepines and nitroglycerine or nitroglycerine alone in the treatment of cocaine-associated acute coronary syndromes. Am. J. Emerg. Med. 2003, 21:39-42.
53. Hysek C.M., Vollenweider F.X., Liechti M.E. Effects of a beta-blocker on the cardiovascular response to MDMA (ecstasy). Emerg. Med. J. 2010, 27:586-589.
54. Hysek C., Schmid Y., Rickli A., Simmler L.D., Donzelli M., Grouzmann E., Liechti M.E. Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans. Br. J. Pharmacol. 2012, 166:2277-2288.
55. 2-adrenergic agonist clonidine on the pharmacodynamics and pharmacokinetics of 3,4-methylenedioxymethamphetamine in healthy volunteers. J. Pharmacol. Exp. Ther. 2012, 340:286-294.
56. 1-Adrenergic receptors contribute to the acute effects of 3,4-methylenedioxymethamphetamine in humans. J. Clin. Psychopharmacol. 2013, 33:658-666.
57. Imam S.F., Patel H., Mahmoud M., Prakash N.A., King M.S., Fremont R.D. Bath salts intoxication: a case series. J. Emerg. Med. 2013, 45:361-365.
58. Jacobsen T.N., Grayburn P.A., Snyder R.W., Hansen J., Chavoshan B., Landau C., Lange R.A., Hillis L.D., Victor R.G. Effects of intranasal cocaine on sympathetic nerve discharge in humans. J. Clin. Invest. 1997, 99:628-634.
59. Jha A., Fourie H. Risperidone treatment of amphetamine psychosis. Br. J. Psychiatry 1999, 174:366.
60. Johnson B.A., Ait-Daoud N., Wells L.T. Effects of isradipine, a dihydropyridine-class calcium channel antagonist, on d-methamphetamine-induced cognitive and physiological changes in humans. Neuropsychopharmacology 2000, 22:504-512.
61. Johnson B.A., Wells L.T., Roache J.D., Wallace C., Ait-Daoud N., Wang Y. Isradipine decreases the hemodynamic response of cocaine and methamphetamine results from two human laboratory studies: results from two human laboratory studies. Am. J. Hypertens. 2005, 18:813-822.
62. Johnson T.D., Berenson M.M. Methamphetamine-induced ischemic colitis. J. Clin. Gastroenterol. 1991, 13:687-689.
63. Joksovic P., Mellos N., van Wattum P.J., Chiles C. Dr Joksovic and colleagues reply. J. Clin. Psychiatry 2013, 74:518-519.
64. Kasick D.P., McKnight C.A., Klisovic E. "Bath salt" ingestion leading to severe intoxication delirium: two cases and a brief review of the emergence of mephedrone use. Am. J. Drug Alcohol Abuse 2012, 38:176-180.
65. Kaye S., McKetin R., Duflou J., Darke S. Methamphetamine and cardiovascular pathology: a review of the evidence. Addiction 2007, 102:1204-1211.
66. Kiely E., Lee C.J., Marinetti L. A fatality from an oral ingestion of methamphetamine. J. Anal. Toxicol. 2009, 33:557-560.
67. Koerselman G.F., Goslinga H. Acute circulatory shock as a side effect of droperidol in a patient addicted to hard drugs with amphetamine poisoning. Ned. Tijdschr. Geneeskd. 1987, 131:1047-1049.
68. Kotani Y., Shimazawa M., Yoshimura S., Iwama T., Hara H. The experimental and clinical pharmacology of propofol, an anesthetic agent with neuroprotective properties. CNS Neurosci. Ther. 2008, 14:95-9106.
69. Lakhan S.E., Kirchgessner A. Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: misuse, cognitive impact, and adverse effects. Brain Behav. 2012, 2:661-677.
70. Lange R.A., Cigarroa R.G., Yancy C.W., Willard J.E., Popma J.J., Sills M.N., McBride W., Kim A.S., Hillis L.D. Cocaine-induced coronary-artery vasoconstriction. N. Engl. J. Med. 1989, 321:1557-1562.
71. Le Cong M., Gynther B., Hunter E., Schuller P. Ketamine sedation for patients with acute agitation and psychiatric illness requiring aeromedical retrieval. Emerg. Med. J. 2012, 29:335-337.
72. Lee H.M.D., Wood D.M., Hudson S., Archer J.R.H., Dargan P.I. Acute toxicity associated with analytically confirmed recreational use of methiopropamine (1-(thiophen-2-yl)-2-methylaminopropane). J. Med. Toxicol. 2014, 10:299-302.
73. Leelahanaj T., Kongsakon R., Netrakom P. A 4-week, double-blind comparison of olanzapine with haloperidol in the treatment of amphetamine psychosis. J. Med. Assoc. Thail. 2005, 88(Suppl. 3):43-52.
74. Leikin J.B. Cocaine and beta-adrenergic blockers: a remarriage after a decade-long divorce?. Crit. Care Med. 1999, 27:688-689.
75. Lidder S., Dargan P., Sexton M., Button J., Ramsey J., Holt D., Wood D. Cardiovascular toxicity associated with recreational use of diphenylprolinol (diphenyl-2-pyrrolidinemethanol [D2PM]). J. Med. Toxicol. 2008, 4:167-169.
76. Lusthof K.J., Oosting R., Maes A., Verschraagen M., Dijkhuizen A., Sprong A.G.A. A case of extreme agitation and death after the use of mephedrone in The Netherlands. Forensic Sci. Int. 2011, 206:93-95.
77. Machado A., Cerqueira J., Rodrigues M., Soares-Fernandes J. Is methylphenidate-induced chorea responsive to chlorpromazine?. J. Neuropsychiatry Clin. Neurosci. 2010, 22. 352n.e20-352.e20.
78. Mangewala V., Sarwar S.R., Shah K., Singh T. Bath salts-induced psychosis: a case report. Innov. Clin. Neurosci. 2013, 10:10-11.
79. Manini A.F., Kabrhel C., Thomsen T.W. Acute myocardial infarction after over-the-counter use of pseudoephedrine. Ann. Emerg. Med. 2005, 45:213-216.
80. Mariani P.J. Pseudoephedrine-induced hypertensive emergency: treatment with labetalol. Am. J. Emerg. Med. 1986, 4:141-142.
81. Mariani P.J. Beta-blockers following cocaine use: a reappraisal. Ann. Emerg. Med. 2008, 52:89-90.
82. Marti G., Fattinger K., Zimmermann H., Exadaktylos A. Orofacial dyskinesia induced by nasal Ritalin(R) (methylphenidate) sniffing: a rare case report from Switzerland. Hum. Exp. Toxicol. 2013, 32:332-334.
83. Mendelson J., Uemura N., Harris D., Nath R.P., Fernandez E., Jacob P., Everhart E.T., Jones R.T. Human pharmacology of the methamphetamine stereoisomers. Clin. Pharmacol. Ther. 2006, 80:403-420.
84. Misra L., Kofoed L. Risperidone treatment of methamphetamine psychosis. Am. J. Psychiatry 1997, 154:1170.
85. Misra L.K., Kofoed L., Oesterheld J.R., Richards G.A. Olanzapine treatment of methamphetamine psychosis. J. Clin. Psychopharmacol. 2000, 20:393-394.
86. Mores N., Campia U., Navarra P., Cardillo C., Preziosi P. No cardiovascular effects of single-dose pseudoephedrine in patients with essential hypertension treated with beta-blockers. Eur. J. Clin. Pharmacol. 1999, 55:251-254.
87. Murphy C.M., Dulaney A.R., Beuhler M.C., Kacinko S. "Bath salts" and "plant food" products: the experience of one regional US poison center. J. Med. Toxicol. 2013, 9:42-48.
88. Negus B.H., Willard J.E., Hillis L.D., Glamann D.B., Landau C., Snyder R.W., Lange R.A. Alleviation of cocaine-induced coronary vasoconstriction with intravenous verapamil. Am. J. Cardiol. 1994, 73:510-513.
89. Nurnberger J.I., Simmons-Alling S., Kessler L., Jimerson S., Schreiber J., Hollander E., Tamminga C.A., Nadi N.S., Goldstein D.S., Gershon E.S. Separate mechanisms for behavioral, cardiovascular, and hormonal responses to dextroamphetamine in man. Psychopharmacology (Berl.) 1984, 84:200-204.
90. O'Connell M.B., Gross C.R. The effect of single-dose phenylpropanolamine on blood pressure in patients with hypertension controlled by beta blockers. Pharmacotherapy 1990, 10:85-91.
91. O'Connell M.B., Gross C.R. The effect of multiple doses of phenylpropanolamine on the blood pressure of patients whose hypertension was controlled with beta blockers. Pharmacotherapy 1991, 11:376-381.
92. Olson K.R. What is the best treatment for acute calcium channel blocker overdose?. Ann. Emerg. Med. 2013, 62:259-261.
93. Oxford Centre for Evidence-Based Medicine Levels of Evidence Working Group OCEBM Levels of Evidence System 2011, (accessed 12.07.14). http://www.cebm.net/index.aspx?o=5653.
94. Page R.L., Utz K.J., Wolfel E.E. Should beta-blockers be used in the treatment of cocaine-associated acute coronary syndrome?. Ann. Pharmacother. 2007, 41:2008-2013.
95. Panenka W.J., Procyshyn R.M., Lecomte T., MacEwan G.W., Flynn S.W., Honer W.G., Barr A.M. Methamphetamine use: a comprehensive review of molecular, preclinical and clinical findings. Drug Alcohol Depend. 2013, 129:167-179.
96. Penders T.M., Gestring R.E., Vilensky D.A. Excited delirium following use of synthetic cathinones (bath salts). Gen. Hosp. Psychiatry 2012, 34:647-650.
97. Pentel P.R., Asinger R.W., Benowitz N.L. Propranolol antagonism of phenylpropanolamine-induced hypertension. Clin. Pharmacol. Ther. 1985, 37:488-494.
98. Perry P.J., Juhl R.P. Amphetamine psychosis. Am. J. Hosp. Pharm. 1977, 34:883-885.
99. Ragland A.S., Ismail Y., Arsura E.L. Myocardial infarction after amphetamine use. Am. Heart J. 1993, 125:247-249.
100. Richards J.R., Bretz S.W., Johnson E.B., Turnipseed S.D., Brofeldt B.T., Derlet R.W. Methamphetamine abuse and emergency department utilization. West. J. Med. 1999, 170:198-202.
101. Richards J.R., Derlet R.W., Duncan D.R. Methamphetamine toxicity: treatment with a benzodiazepine versus a butyrophenone. Eur. J. Emerg. Med. 1997, 4:130-135.
102. Richards J.R., Johnson E.B., Stark R.W., Derlet R.W. Methamphetamine abuse and rhabdomyolysis in the ED: a 5-year study. Am. J. Emerg. Med. 1999, 17:681-685.
103. Roberts J.R., Geeting G.K. Intramuscular ketamine for the rapid tranquilization of the uncontrollable, violent, and dangerous adult patient. J. Trauma 2001, 51:1008-1010.
104. Rosen R.A. Angina associated with pseudoephedrine. Ann. Emerg. Med. 1981, 10:230-231.
105. Ruha A.-M., Yarema M.C. Pharmacologic treatment of acute pediatric methamphetamine toxicity. Pediatr. Emerg. Care 2006, 22:782-785.
106. Sakuragi T., Yasumoto M., Higa K., Nitahara K. Inadvertent intravenous administration of a high dose of ephedrine. J. Cardiothorac. Vasc. Anesth. 2004, 18:121.
107. Scharman E.J., Erdman A.R., Cobaugh D.J., Olson K.R., Woolf A.D., Caravati E.M., Chyka P.A., Booze L.L., Manoguerra A.S., Nelson L.S., Christianson G., Troutman W.G., American Association of Poison Control Centers Methylphenidate poisoning: an evidence-based consensus guideline for out-of-hospital management. Clin. Toxicol. (Phila.) 2007, 45:737-752.
108. Schurr J.W., Gitman B., Belchikov Y. Controversial therapeutics: the beta-adrenergic antagonist and cocaine-associated cardiovascular complications dilemma. Pharmacotherapy 2014, 34:1269-1281.
109. Shen Y.C. Amphetamine as a risk factor for aripiprazole-induced acute dystonia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:1756-1757.
110. Shoptaw S.J., Kao U., Heinzerling K., Ling W. Treatment for amphetamine withdrawal. Cochrane Database Syst. Rev. 2009, CD003021.
111. Short T.G., Forrest P., Galletly D.C. Paradoxical reactions to benzodiazepines - a genetically determined phenomenon?. Anaesth. Intensive Care 1987, 15:330-331.
112. Silverman S.H., Turner W.W. Intraarterial drug abuse: new treatment options. J. Vasc. Surg. 1991, 14:111-116.
113. Starcevic B., Sicaja M. Dual intoxication with diazepam and amphetamine: this drug interaction probably potentiates myocardial ischemia. Med. Hypotheses 2007, 69:377-380.
114. Stewart J.L., Meeker J.E. Fetal and infant deaths associated with maternal methamphetamine abuse. J. Anal. Toxicol. 1997, 21:515-517.
115. Substance Abuse and Mental Health Services Administration National Estimates of Drug-related Emergency Department Visits 2011, (accessed 12.07.14). http://www.samhsa.gov/data/2k13/DAWN2k11ED/DAWN2k11ED.htm.
116. Substance Abuse and Mental Health Services Administration (2012). (accessed 12.07.2014). http://www.samhsa.gov/data/NSDUH/2012SummNatFindDetTables/NationalFindings/NSDUHresults2012.htm.
117. Sulaiman A.H., Gill J.S., Said M.A., Zainal N.Z., Hussein H.M., Guan N.C. A randomized, placebo-controlled trial of aripiprazole for the treatment of methamphetamine dependence and associated psychosis. Int. J. Psychiatry Clin. Pract. 2013, 17:131-138.
118. Sutamtewagul G., Sood V., Nugent K. Sympathomimetic syndrome, choreoathetosis, and acute kidney injury following "bath salts" injection. Clin. Nephrol. 2014, 81:63-66.
119. Swanson S.M., Sise C.B., Sise M.J., Sack D.I., Holbrook T.L., Paci G.M. The scourge of methamphetamine: impact on a level I trauma center. J. Trauma 2007, 63:531-537.
120. Thompson C.A. Pulmonary arterial hypertension seen in methamphetamine abusers. Am. J. Health Syst. Pharm. 2008, 65:1109-1110.
121. Thornton S.L., Gerona R.R., Tomaszewski C.A. Psychosis from a bath salt product containing flephedrone and MDPV with serum, urine, and product quantification. J. Med. Toxicol. 2012, 8:310-313.
122. Ting J.Y.S., Chatterjee R. Using propofol as salvage therapy to contain severe drug-induced agitation in the Emergency Department: a case report. Eur. J. Emerg. Med. 2008, 15:242-243.
123. Tobias J.D. Dexmedetomidine to control agitation and delirium from toxic ingestions in adolescents. J. Pediatr. Pharmacol. Ther. 2010, 15:43-48.
124. Turnipseed S.D., Richards J.R., Kirk J.D., Diercks D.B., Amsterdam E.A. Frequency of acute coronary syndrome in patients presenting to the emergency department with chest pain after methamphetamine use. J. Emerg. Med. 2003, 24:369-373.
125. Uday G.J., Josh U.G., Bhat S.M. Mephentermine dependence with psychosis. A case report. Br. J. Psychiatry 1988, 152:129-131.
126. United Nations Office on Drugs and Crime (UNODC) World Drug Report 2012 2012, (accessed 12.07.14). http://www.unodc.org/documents/data-and-analysis/WDR2012/WDR_2012_web_small.pdf.
127. U.S.Department of Justice Drug Enforcement Agency National Drug Threat Assessment Summary 2013, (accessed 12.07.14). http://www.justice.gov/dea/resource-center/DIR-017-13NDTASummaryfinal.pdf.
128. Urban M., Rudecki T., Wroblewski D., Rabe-Jablonska J. Psychotic disorders related with chronic use of mephedrone. Case report. Psychiatr. Pol. 2011, 45:431-437.
129. Verachai V., Rukngan W., Chawanakrasaesin K., Nilaban S., Suwanmajo S., Thanateerabunjong R., Kaewkungwal J., Kalayasiri R. Treatment of methamphetamine-induced psychosis: a double-blind randomized controlled trial comparing haloperidol and quetiapine. Psychopharmacology (Berl.) 2014, 231:3099-3108.
130. Visser S.N., Danielson M.L., Bitsko R.H., Holbrook J.R., Kogan M.D., Ghandour R.M., Perou R., Blumberg S.J. Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit/hyperactivity disorder: United States, 2003-2011. J. Am. Acad. Child Adolesc. Psychiatry 2014, 53:34-46.
131. Wilson M.P., Pepper D., Currier G.W., Holloman G.H., Feifel D. The psychopharmacology of agitation: consensus statement of the American Association for Emergency Psychiatry Project Beta Psychopharmacology Workgroup. West. J. Emerg. Med. 2012, 13:26-34.
132. Weesner K.M., Denison M., Roberts R.J. Cardiac arrhythmias in an adolescent following ingestion of an over-the-counter stimulant. Clin. Pediatr. (Phila.) 1982, 21:700-701.
133. Westover A.N., McBride S., Haley R.W. Stroke in young adults who abuse amphetamines or cocaine: a population-based study of hospitalized patients. Arch. Gen. Psychiatry 2007, 64:495-502.
134. Wiener I., Tilkian A.G., Palazzolo M. Coronary artery spasm and myocardial infarction in a patient with normal coronary arteries: temporal relationship to pseudoephedrine ingestion. Catheter. Cardiovasc. Diagn. 1990, 20:51-53.
135. Won S., Hong R.A., Shohet R.V., Seto T.B., Parikh N.I. Methamphetamine-associated cardiomyopathy. Clin. Cardiol. 2013, 36:737-742.
136. Wood D.M., Davies S., Greene S.L., Button J., Holt D.W., Ramsey J., Dargan P.I. Case series of individuals with analytically confirmed acute mephedrone toxicity. Clin. Toxicol. (Phila.) 2010, 48:924-927.
137. Wood D.M., Davies S., Puchnarewicz M., Button J., Archer R., Ovaska H., Ramsey J., Lee T., Holt D.W., Dargan P.I. Recreational use of mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity. J. Med. Toxicol. 2010, 6:327-330.
138. Wood D.M., Greene S.L., Dargan P.I. Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone. Emerg. Med. J. 2011, 28:280-282.
139. Wood D.M., Puchnarewicz M., Johnston A., Dargan P.I. A case series of individuals with analytically confirmed acute diphenyl-2-pyrrolidinemethanol (D2PM) toxicity. Eur. J. Clin. Pharmacol. 2012, 68:349-353.
140. Wood K.E. Exposure to bath salts and synthetic tetrahydrocannabinol from 2009 to 2012 in the United States. J. Pediatr. 2013, 163:213-216.
141. Wujtewicz M., Maciejewski D., Misiolek H., Fijalkowska A., Gaszynski T., Knapik P., Lango R. Use of dexmedetomidine in the adult intensive care unit. Anaesthesiol. Intensive Ther. 2013, 45:235-240.
142. Yeh T.-C., Lin Y.-C., Chen L.-F., Chiang C.-P., Mao W.-C., Chang H.-A., Kao Y.-C., Tzeng N.-S. Aripiprazole treatment in a case of amphetamine-induced delusional infestation. Aust. N. Z. J. Psychiatry 2014, 48:681-682.
143. Zahn K.A., Li R.L., Purssell R.A. Cardiovascular toxicity after ingestion of "herbal ecstasy". J. Emerg. Med. 1999, 17:289-291.